HomeInsightsPE

Genpharmasec Ltd P/E Ratio

Genpharmasec Ltd P/E Ratio

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

609.9 K

stocks traded

Last Updated time: 22 Jul 9.00 AM

Image

Genpharmasec Ltd

NSE: GENPHARMASEC

PE

0

Last updated : 22 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Genpharmasec Ltd is 0 as of 22 Jul 9.00 AM .a1#The P/E Ratio of Genpharmasec Ltd changed from 77.8 on March 2023 to 0 on March 2024 . This represents a CAGR of -100.00% over 2 years. a1#The Latest Trading Price of Genpharmasec Ltd is ₹ 2.2 as of 22 Jul 15:30 .a1#The PE Ratio of Trading Industry has changed from 24.9 to 44.0 in 5 years. This represents a CAGR of 12.06%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Finance industry is 23.8. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.4. The PE Ratio of Trading industry is 71.5. In 2024a1#The Market Cap of Genpharmasec Ltd changed from ₹ 86.1 crore on March 2023 to ₹ 123.48 crore on March 2024 . This represents a CAGR of 19.76% over 2 years. a1#The Revenue of Genpharmasec Ltd changed from ₹ 6.27 crore to ₹ 10.51 crore over 3 quarters. This represents a CAGR of 99.12% a1#The EBITDA of Genpharmasec Ltd changed from ₹ 0.26 crore to ₹ 0.3 crore over 3 quarters. This represents a CAGR of 21.02% a1#The Net Pr of Genpharmasec Ltd changed from ₹ 1.05 crore to ₹ -0.27 crore over 3 quarters. This represents a CAGR of NaN% a1#The Dividend Payout of Genpharmasec Ltd changed from 0 % on March 2019 to 0 % on March 2024 . This represents a CAGR of 0.0% over 6 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Genpharmasec Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Genpharmasec Ltd

Period
Mar '2377.8
Mar '240

Company Fundamentals for Genpharmasec Ltd

Market Cap

121 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

1.9

Day’s High

2.25

Day’s Low

2.16

DTE *

0.1

ROE *

-0.2

52 Week High

7.31

52 Week Low

1.69

ROCE *

1.0

* All values are consolidated

Last Updated time: 22 Jul 9.00 AM

* All values are consolidated

Last Updated time: 22 Jul 9.00 AM

Image

Genpharmasec Ltd

NSE: GENPHARMASEC

PRICE

2.2

-0.07 (-3.08%)

stock direction

Last updated : 22 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Genpharmasec Ltd

Strength

0

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Genpharmasec Ltd

Market Value

122

Asset Value

40

2.1 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Genpharmasec Ltd0121
Adani Enterprises Ltd97342,017
Aegis Logistics Ltd5229,658
Cello World Ltd6320,952
Redington Ltd1315,823
Honasa Consumer Ltd13415,025

Key Valuation Metric of Genpharmasec Ltd

Earnings

0 Cr

0.0 X

PE Ratio

Market Cap

₹121.82Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

0 Cr

0.0 X

PE Ratio

Market Cap

₹121.82Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Trading Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Genpharmasec Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Genpharmasec Ltd

Period
Mar '2386
Mar '24123

* All values are a in crore

×

Historical Revenue of Genpharmasec Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Genpharmasec Ltd

Period
Mar '236
Dec '237
Mar '2411

* All values are a in crore

×

Historical EBITDA of Genpharmasec Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Genpharmasec Ltd

Period
Mar '230
Dec '230
Mar '240

* All values are a in crore

×

Historical Net Profit of Genpharmasec Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Genpharmasec Ltd

Period
Mar '231
Dec '230
Mar '240

* All values are a in crore

×

Historical Dividend Payout of Genpharmasec Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Genpharmasec Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230
Mar '240

* All values are a in %

About Genpharmasec Ltd

About Genpharmasec Ltd

    Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in the State of Gujarat as 'Adi Rasayan Limited'. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from 'Adi Rayasan Limited' to 'Genpharmasec Limited' on 27th November, 2018. Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited' to ' Genpharmasec Limited' on 25th October, 2021 a fresh Certificate of Incorporation consequent upon the name change was obtained from the Registrar of Companies at Mumbai. The company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat. Initially, the Company started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, ity shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market. In year 2019, the Company focused to the lucrative medical and diagnostics device segment. The Company tied up with Abbott Point of Care Corporation INC, USA for distribution of their niche diagnostic equipment namely, i-STAT 1 Analyzer which is a hand-held blood analyzer exclusively used in ICUs and ICCUs of hospitals for immediate test results.

Genpharmasec Ltd News Hub

News

Genpharmasec AGM scheduled

Genpharmasec announced that the Annual General Meeting (AGM) of the company will be held o...

Read more

28 Jun 202414:06

News

Genpharmasec to hold board meeting

Genpharmasec will hold a meeting of the Board of Directors of the Company on 27 June 2024....

Read more

25 Jun 202409:42

News

Genpharmasec to convene board meeting

Genpharmasec will hold a meeting of the Board of Directors of the Company on 24 May 2024 P...

Read more

14 May 202417:12

News

Genpharmasec to conduct board meeting

Genpharmasec will hold a meeting of the Board of Directors of the Company on 27 March 2024...

Read more

21 Mar 202413:44

News

Genpharmasec to convene board meeting

Genpharmasec will hold a meeting of the Board of Directors of the Company on 26 March 2024...

Read more

21 Mar 202410:15

News

Genpharmasec to conduct board meeting

Genpharmasec will hold a meeting of the Board of Directors of the Company on 12 February 2...

Read more

06 Feb 202415:46

Product Composition by Percentage (Revenue)

FAQs for PE of Genpharmasec Ltd

What is Genpharmasec Ltd current share price?

The current market price of Genpharmasec Ltd as of July 22, 2024 is ₹2.20.

What is Genpharmasec Ltd's market cap?

Genpharmasec Ltd's market capitalisation stood at ₹121 Cr as of July 22, 2024

What are Genpharmasec Ltd's total net assets?

According to Genpharmasec Ltd's most recent financial filings, the company's net assets total ₹39.7 Cr.

Is Genpharmasec Ltd making a profit or loss?

Genpharmasec Ltd's net Profit as of July 22, 2024 is close to ₹0 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199